Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Ahmet Kursad Gunes"'
Autor:
Fatma Yılmaz, Bugra Saglam, Ufuk Gorduk, Ugur Kalan, Hacer Berna Afacan Öztürk, Ahmet Kursad Gunes, Murat Albayrak
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 16, Iss 1 (2024)
Introduction. Patients with leukaemia are exposed to infections as long as they are neutropenic. During this period, anorectal pathologies are among the common foci of infection with high mortality. We aimed in this study to investigate the factors t
Externí odkaz:
https://doaj.org/article/3ca76beb2ee045728e12e60fc9aa39cf
Autor:
Zehra Narli Ozdemir, Mesude Falay, Ayhan Parmaksiz, Eylem Genc, Ozlem Beyler, Ahmet Kursad Gunes, Funda Ceran, Simten Dagdas, Gulsum Ozet
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss 2, Pp 176-181 (2023)
Introduction: The availability of a clinical decision algorithm for diagnosis of chronic lymphocytic leukemia (CLL) may greatly contribute to the diagnosis of CLL, particularly in cases with ambiguous immunophenotypes. Herein we propose a novel diffe
Externí odkaz:
https://doaj.org/article/4b375ad0b5a6408db3206a3be4c56612
Autor:
Ozlem Beyler, Merve Pamukçuoğlu, Ahmet Kursad Gunes, Gulten Korkmaz, Funda Ceran, Simten Dağdaş, Gülsüm Özet
Publikováno v:
HemaSphere, Vol 7, p e2048908 (2023)
Externí odkaz:
https://doaj.org/article/34e820b486dc4bd88f424e63b9f0d79f
Autor:
Serdal Korkmaz, Mehmet Sinan Dal, Ahmet Kursad Gunes, Nurhilal Büyükkurt, Özgür Mehtap, Meliha Nalcaci, Fehmi Hindilerden, Tuğçe Nur Yiğenoğlu, Semih Başcı, Gülsüm Özet, Burhan Ferhanoglu, Didar Yanardag Acik, Olga Meltem Akay, Merih Kızıl Çakar, Turgay Ulas, Fevzi Altuntaş, İpek Yönal Hindilerden, Bahar Uncu Ulu
Publikováno v:
Journal of Chemotherapy. 34:190-198
© 2021 Edizioni Scientifi che per l'Informazione su Farmaci e Terapia.The prognosis is poor for relapsed or refractory (R/R) classical Hodgkin Lymphoma (cHL) patients. The brentuximab vedotin (Bv) and bendamustine (B) combination has been used as a
Autor:
Muruvvet Seda Aydin, Gülsüm Özet, Funda Ceran, Simten Dagdas, Mehmet Ali Ucar, Ahmet Kursad Gunes, Esra Cengiz
Publikováno v:
Medical Science and Discovery. 8:485-491
Objective: Myeloid growth factors have been often used in allogeneic hematopoietic stem cell transplantation settings. There are some controversies about increased graft versus host disease, relapse, and delayed platelet engraftment with those growth
Autor:
Cenk Sunu, Ahmet Kursad Gunes, Gulten Korkmaz Akat, Yasin Kalpakci, Funda Ceran, Simten Dagdas, Gulsum Ozet
Publikováno v:
Revista da Associação Médica Brasileira v.67 n.3 2021
Revista da Associação Médica Brasileira
Associação Médica Brasileira (AMB)
instacron:AMB
Revista da Associação Médica Brasileira, Volume: 67, Issue: 3, Pages: 385-389, Published: 27 AUG 2021
Revista da Associação Médica Brasileira, Vol 67, Iss 3, Pp 385-389 (2021)
Revista da Associação Médica Brasileira
Associação Médica Brasileira (AMB)
instacron:AMB
Revista da Associação Médica Brasileira, Volume: 67, Issue: 3, Pages: 385-389, Published: 27 AUG 2021
Revista da Associação Médica Brasileira, Vol 67, Iss 3, Pp 385-389 (2021)
SUMMARY OBJECTIVE: The aim of this study was to compare the incidence of factors associated with an increased risk of thrombosis in patients with essential thrombocythemia. METHODS: A total of 200 patients followed-up in our unit with a diagnosis of
Autor:
Yasin Kalpakci, Funda Ceran, Cenk Sunu, Ahmet Kursad Gunes, Gulten Korkmaz Akat, Simten Dağdaş, Gülsüm Özet
Publikováno v:
Acta Oncologica Turcica. 54:31-39
Autor:
Funda Ceran, Mesude Falay, Gülsüm Özet, Merve Pamukçuoğlu, Ahmet Kursad Gunes, Simten Dağdaş, Mehmet Ali Ucar
Publikováno v:
Acta Oncologica Turcica. 54:224-232
Publikováno v:
International Journal of Hematology and Oncology. 30:121-125
The new coronavirus disease-2019 (COVID-19) is rapidly spreading around the world and has been declared an outbreak by WHO However, the effect of blood groups on COVID-19 infection and the severity of the disease is unclear The aim of this study is t
Autor:
Hasan Sami Goksoy, Sevgi Kalayoglu Besisik, Zübeyde Nur Özkurt, Mehmet Sönmez, Sinem Civriz Bozdag, Irfan Yavasoglu, Tugrul Elverdi, Özgür Mehtap, Orhan Ayyildiz, Ahmet Kursad Gunes, Meliha Nalcaci, Burhan Ferhanoglu, Sebnem Izmir Guner, Meltem Kurt Yuksel, Elif Birtas Atesoglu, Selami Kocak Toprak, Tuğçe Nur Yiğenoğlu, Mustafa Pehlivan, Birol Yildiz, Ozan Salim, Rahsan Yildirim, Tayfur Toptas, Leylagül Kaynar, Ant Uzay, Murat Albayrak, Gülsüm Özet, Güray Saydam, Murat Ozbalak, Fevzi Altuntaş, İpek Yönal Hindilerden, Meltem Ayli, Olga Meltem Akay, Mehmet Hilmi Dogu
Publikováno v:
Web of Science
The AETHERA trial reported an increased progression-free survival (PFS) when brentuximab vedotin (BV) was used as maintenance therapy in high-risk Hodgkin lymphoma (HL) after autologous stem cell transplantation (ASCT). Thus, we aimed to determine th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95a7c1c4c72fda6e1343d54d2a49939b
https://avesis.gazi.edu.tr/publication/details/e5a6129e-18e7-4d48-aaf0-2f5c1ba61d94/oai
https://avesis.gazi.edu.tr/publication/details/e5a6129e-18e7-4d48-aaf0-2f5c1ba61d94/oai